Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Krystal Biotech (KRYS) Other Gross PP&E Adjustments (2021 - 2025)

Historic Other Gross PP&E Adjustments for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $164.2 million.

  • Krystal Biotech's Other Gross PP&E Adjustments fell 206.9% to $164.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $164.2 million, marking a year-over-year decrease of 206.9%. This contributed to the annual value of $168.1 million for FY2024, which is 536.58% up from last year.
  • Krystal Biotech's Other Gross PP&E Adjustments amounted to $164.2 million in Q3 2025, which was down 206.9% from $164.1 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Other Gross PP&E Adjustments high stood at $168.1 million for Q4 2024, and its period low was $32.4 million during Q1 2021.
  • Its 5-year average for Other Gross PP&E Adjustments is $138.7 million, with a median of $159.6 million in 2023.
  • As far as peak fluctuations go, Krystal Biotech's Other Gross PP&E Adjustments surged by 29822.78% in 2022, and later crashed by 206.9% in 2025.
  • Quarter analysis of 5 years shows Krystal Biotech's Other Gross PP&E Adjustments stood at $105.4 million in 2021, then soared by 45.1% to $153.0 million in 2022, then rose by 4.31% to $159.6 million in 2023, then increased by 5.37% to $168.1 million in 2024, then decreased by 2.32% to $164.2 million in 2025.
  • Its last three reported values are $164.2 million in Q3 2025, $164.1 million for Q2 2025, and $163.4 million during Q1 2025.